These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 12783488)

  • 1. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24.
    Müthing J; Kemminer SE; Conradt HS; Sagi D; Nimtz M; Kärst U; Peter-Katalinić J
    Biotechnol Bioeng; 2003 Aug; 83(3):321-34. PubMed ID: 12783488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24.
    Kemminer SE; Conradt HS; Nimtz M; Sagi D; Peter-Katalinić J; Diekmann O; Drmić I; Müthing J
    Biotechnol Prog; 2001; 17(5):809-21. PubMed ID: 11587568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.
    Saba JA; Kunkel JP; Jan DC; Ens WE; Standing KG; Butler M; Jamieson JC; Perreault H
    Anal Biochem; 2002 Jun; 305(1):16-31. PubMed ID: 12018942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors.
    Kunkel JP; Jan DC; Butler M; Jamieson JC
    Biotechnol Prog; 2000; 16(3):462-70. PubMed ID: 10835250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media.
    Serrato JA; Hernández V; Estrada-Mondaca S; Palomares LA; Ramírez OT
    Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):113-24. PubMed ID: 17250495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor.
    Ozturk SS; Palsson BO
    Biotechnol Prog; 1991; 7(6):481-94. PubMed ID: 1367750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous production of monoclonal antibody in a packed-bed bioreactor.
    Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of culture conditions on the N-glycosylation of a monoclonal antibody specific for recombinant hepatitis B surface antigen.
    Cabrera G; Cremata JA; Valdés R; García R; González Y; Montesino R; Gómez H; González M
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):67-76. PubMed ID: 15049731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
    Seifert DB; Phillips JA
    Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of an immunoglobulin produced from a murine hybridoma cell line: the effect of culture mode and the anti-apoptotic gene, bcl-2.
    Majid FA; Butler M; Al-Rubeai M
    Biotechnol Bioeng; 2007 May; 97(1):156-69. PubMed ID: 17013932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
    Dong H; Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery.
    Kundu PK; Prasad NS; Datta D
    Indian J Exp Biol; 1998 Feb; 36(2):125-35. PubMed ID: 9754040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of monoclonal antibodies in culture.
    Reuveny S; Velez D; Riske F; MacMillan JD; Miller L
    Dev Biol Stand; 1985; 60():185-97. PubMed ID: 3930316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific N-glycosylation of chicken serum IgG.
    Suzuki N; Lee YC
    Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular pH monitoring as a tool for the study of hybridoma cell behavior in batch and continuous bioreactor cultures.
    Cherlet M; Marc A
    Biotechnol Prog; 1998; 14(4):626-38. PubMed ID: 9694686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum preparation and methods for the large-scale production of IgG monoclonal antibody.
    Zeng QS; Takeyama H; Kanda S; Irie RF
    Hum Antibodies Hybridomas; 1994; 5(1-2):75-80. PubMed ID: 7858185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting higher yields of monoclonal antibody in culture.
    Kundu PK; Prasad NS; Electricwala SE; Varma R; Datta D
    Indian J Physiol Pharmacol; 1998 Apr; 42(2):155-71. PubMed ID: 10225044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous conditions in dissolved oxygen affect N-glycosylation but not productivity of a monoclonal antibody in hybridoma cultures.
    Serrato JA; Palomares LA; Meneses-Acosta A; Ramírez OT
    Biotechnol Bioeng; 2004 Oct; 88(2):176-88. PubMed ID: 15449295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.